SMTL ID : 8f6s.1

LSD1-CoREST in complex with T105

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.91 Å

Oligo State

hetero-1-1-mer

Ligands

1 x XHT: [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S,3R,4S)-2,3,4-trihydroxy-5-[(1R,3R,3aS,13R)-1-hydroxy-10,11-dimethyl-3-{3-[(5-methyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenyl}-4,6-dioxo-2,3,5,6-tetrahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]pentyl dihydrogen diphosphate (non-preferred name)(Non-covalent)

XHT.1: 42 residues within 4Å: Chain A: G.304, S.305, G.306, V.307, S.308, L.326, E.327, A.328, R.329, G.333, G.334, R.335, V.336, L.348, G.349, A.350, M.351, V.352, T.354, I.375, F.557, H.583, T.607, A.608, V.609, T.643, L.644, P.645, V.648, V.656, W.714, W.770, W.775, S.779, Y.780, G.819, E.820, A.828, T.829, V.830, A.833 Ligands: XHX.2 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:R.335, A:V.352, A:T.354, A:I.375, A:Y.780 Hydrogen bonds: A:S.305, A:S.308, A:S.308, A:A.328, A:G.333, A:R.335, A:M.351, A:V.352, A:V.352, A:V.609, A:V.609, A:W.775, A:E.820, A:T.829, A:V.830 Salt bridges: A:R.335, A:R.335 pi-Stacking: A:Y.780

1 x XHX: 3-[(1R,2S)-2-(cyclobutylamino)cyclopropyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide(Non-covalent)

XHX.2: 7 residues within 4Å: Chain A: A.558, N.559, W.571, D.574, H.583, Y.780 Ligands: XHT.1 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:A.558 Hydrogen bonds: A:D.574

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Caroli, J. et al., Distal drug resistance mutations promote covalent inhibitor-adduct Grob fragmentation in LSD1. to be published

Release Date

2024-06-12

Peptides

Lysine-specific histone demethylase 1A: A
REST corepressor 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Lysine-specific histone demethylase 1A

REST corepressor 1

Related Entries With Identical Sequence